Norway
· Delayed Price · Currency is NOK IDEX Biometrics ASA Statistics
Total Valuation
IDEX Biometrics ASA has a market cap or net worth of NOK 102.93 million. The enterprise value is 97.04 million.
| Market Cap | 102.93M |
| Enterprise Value | 97.04M |
Important Dates
The last earnings date was Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IDEX Biometrics ASA has 805.42 million shares outstanding. The number of shares has increased by 23.71% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 805.42M |
| Shares Change (YoY) | +23.71% |
| Shares Change (QoQ) | +7.43% |
| Owned by Insiders (%) | 7.69% |
| Owned by Institutions (%) | 14.51% |
| Float | 743.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.74 |
| PB Ratio | 0.93 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.59 |
| EV / Sales | 7.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.16, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.16 |
| Quick Ratio | 0.61 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.92 |
Financial Efficiency
Return on equity (ROE) is -165.59% and return on invested capital (ROIC) is -124.37%.
| Return on Equity (ROE) | -165.59% |
| Return on Assets (ROA) | -80.72% |
| Return on Capital (ROIC) | -124.37% |
| Revenue Per Employee | 370,545 |
| Profits Per Employee | -4.45M |
| Employee Count | 69 |
| Asset Turnover | 0.08 |
| Inventory Turnover | 0.23 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.00% in the last 52 weeks. The beta is 2.37, so IDEX Biometrics ASA's price volatility has been higher than the market average.
| Beta (5Y) | 2.37 |
| 52-Week Price Change | -94.00% |
| 50-Day Moving Average | 0.19 |
| 200-Day Moving Average | 1.20 |
| Relative Strength Index (RSI) | 24.36 |
| Average Volume (20 Days) | 5,095,718 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDEX Biometrics ASA had revenue of NOK 13.71 million and -164.76 million in losses. Loss per share was -0.59.
| Revenue | 13.71M |
| Gross Profit | -3.29M |
| Operating Income | -224.18M |
| Pretax Income | -164.59M |
| Net Income | -164.76M |
| EBITDA | -213.20M |
| EBIT | -224.18M |
| Loss Per Share | -0.59 |
Balance Sheet
The company has 11.38 million in cash and 5.49 million in debt, giving a net cash position of 5.90 million or 0.01 per share.
| Cash & Cash Equivalents | 11.38M |
| Total Debt | 5.49M |
| Net Cash | 5.90M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 60.38M |
| Book Value Per Share | 0.14 |
| Working Capital | 59.81M |
Cash Flow
| Operating Cash Flow | -188.20M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | -23.96% |
| Operating Margin | -1,635.10% |
| Pretax Margin | -1,200.46% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IDEX Biometrics ASA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.71% |
| Shareholder Yield | -23.71% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
The last stock split was on January 9, 2024. It was a reverse split with a ratio of 0.2.
| Last Split Date | Jan 9, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
IDEX Biometrics ASA has an Altman Z-Score of -37.63. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -37.63 |
| Piotroski F-Score | n/a |